EuroIntervention PCRonline - Connecting with the community

Randomised Trials 2011-2016

1. Drug-eluting stents

1.1 - Drug-eluting stents vs bare metal stents

1.2 - Comparisons drug-eluting stents

1.3 - DES for CTO

1.4 - Peri-procedural MI during PCI

1.5 - With or without on-site cardiac surgery

1.6 - IVUS is angiography-guided DES

1.7 - Vascular closure device

1.8 - Meta-analyses

2. PCI for STEMI

2.1 - Fibrinolysis vs PCI

2.2 - DES vs BMS

2.3 - DES vs DES

2.4 - GP IIB/IIIA

2.5 - Direct thrombin inhibitors

2.6 - Clopidogrel

2.7 - Primary PCI strategies

2.8 - Thrombectomy aspiration

2.9 - Pre-conditioning

2.10 - Cell therapy

2.11 - Hypothermia

2.12 - Meta-analyses

3. PCI in patients with diabetes

3.1 - Stents in diabetics

3.2 - Meta-analyses

4. Stents for left main disease

4.1 - Stents

4.2 - Meta-analyses

5. Stents for bifurcation lesions

5.1 - Stents

5.2 - Meta-analyses

6. Stents for saphenous vein grafts

7. Stent thrombosis

7.1 - Stents

7.2 - Meta-analyses

8. In-stent restenosis

9. Radial vs femoral approach

10. Revascularisation strategy: PCI vs CABG

11. Early invasive vs early conservative strategy ACS

11.1 - Trials

11.2 - Meta-analyses

12. Medical therapy vs PCI – Meta-analyses

13. Various medical therapies and PCI

13.1 - Trials

13.2 - Meta-analyses

14. FFR and PCI

15. Prevention of thrombotic complications during PCI

15.1 - Duration dual antiplatelet treatment

15.2 - Platelet function testing

15.3 - Thienopyridines

15.4 - Abciximab

15.5 - Cangrelor

15.7 - Prasugrel

15.8 - Cilostazol

15.9 - Otamixaban

15.10 - Meta-analyses

16. Aortic balloon counterpulsation

17. Prevention contrast-induced nephropathy

17.1 - Trials

17.2 - Meta-analyses

18. Percutaneous treatment for structural heart disease

18.1 - TAVI and mitral clip

18.2 - Closure foramen ovale

18.3 - Closure left atrial appendage

18.4 - Closure ventricular septal defect

18.5 - Registries – TAVI and mitral clip

18.6 - Meta-analyses

19. Renal denervation

Partners for this issue